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SUMMARY
To establish the sensitivity ofdouble contrast barium enema (DCBE) for detection ofcolorectal
carcinomainatertiaryreferralcentreandconsideritspossibleroleasasuitableimagingmethod
in screening for this disease.
A total of 160 patients with a histopathologically proven diagnosis ofcolorectal carcinoma over
a two year period were reviewed. Subsequently 112 ofthe 160 patients were identified as having
undergone DCBE, the results of which were analysed to determine its sensitivity for detecting
colorectal carcinoma.
Colorectal carcinoma was missed in4 ofthe 112 barium enemasperformed. This corresponds to
asensitivityof96.5% with afalsenegative rateof3.5%. TheDukes Classification inthese4cases
showed that Dukes stage B, C and D were missed, with tumours located in the right and the
sigmoid colon. The mean delay to operation in these four cases was 6 weeks.
Our study correlates with previous studies showing a false negative rate for DCBE of 3.5%.
Colonoscopy also fails to detect small numbers oftumours with false negative rates reported as
high as 10%. We suggest that double contrast barium enema should be effective as a screening
method in any future colorectal cancer screening program.
INTRODUCTION
Colorectal cancer is the second most common
malignancy in the United Kingdom with 28,000
newcaseseachyear.Thereare600newcasesand
480 deaths per annum in Northern Ireland. We
wished to examine the sensitivity of double
contrastbarium enema (DCBE) forthedetection
ofcolorectalcarcinomainatertiaryreferralcentre
and consider its possible role as an imaging
method in screening for this disease.
MATERIALS AND METHODS
Allhistopathologicallyprovencasesofcolorectal
carcinoma in the Royal Victoria Hospital within
a two-year period were reviewed. A total of 160
patients werefoundtohavecolorectalcarcinoma
over this 2 year period. Subsequently 112 ofthe
160patients wereidentifiedashavingundergone
barium enema examinations. The remaining 48
patientswithcolorectalcarcinomawereexcluded
from the study as they had the diagnosis
established by means other than barium enema.
The examinations were performed using a
standard double contrast technique, following
colonic preparation with 10 mg sodium
picosulphate (Picolax, Nordic) at 8 am and 6 pm
on the day before the examination, and a clear
fluiddiet. Hyoscinebromideorglucagonwasnot
used routinely.
RESULTS
Colorectal carcinoma was not identified in 4 of
the 112bariumenemasperformed(TableI). This
corresponds to asensitivity of96.5% withafalse
negative rate of 3.5%. The age range ofpatients
with unidentified tumours was 59 to 78 years,
with an average age of 68 years.
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TABLE I
Undidentified colorectal carcinomasfollowing DCBE
Duke's Delay to Diverticulosis FaecalResidue
Age Site Stage Operation Present? Present?
Missed 73 yrs Caecum D 10 Days No Yes
Tumour 1
Missed 69 yrs Sigmoid D 9 Weeks Yes Yes
Tumour 2
Missed 59 yrs Recto-sigmoid C 9 Weeks Yes No
Tumour 3
Missed 63 yrs Recto-sigmoid B 8 weeks No No
Tumour 4
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Fig I (a & b). Single and double contrast barium enema views of a colorectal carcinoma that was not identified in the
mid-sigmoid colon.
One malignancy was missed in the caecum. In
this case, marked right-sided faecal residue had
been noted in the caecum and although no gross
abnormalitywasnotedonthereport, aCTscanof
abdomenwasrecommendedtoevaluatetheregion
further.Thismalignancywassubsequentlystaged
as a Dukes stage D carcinoma and the delay to
operation following the barium enema was 10
days.
The three remaining unidentified malignancies
were in the sigmoid colon or at the rectosigmoid
junction. The unidentified sigmoid lesion
measured 3 cm and involved the full
circumference ofthe sigmoid colon. This patient
wasstaged, subsequently, asaDukesDcolorectal
cancer. It was visible onretrospective reanalysis
ofthe barium enema films (Figs.1). The delay to
operation was 9 weeks.
The2remainingunidentifiedlesionswerepolyps
atthe recto-sigmoidjunction, one measuring 1.3
cm and the other 2.5 cm. The delay to operation
was again between 8 and 9 weeks. Neither of
these2polypscouldbeidentifiedonretrospective
viewing ofthe films.
DISCUSSION
Screening for colorectal carcinoma has not yet
received widespread acceptance; however, there
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isindirectevidencethatscreeningforthisdisease
betweentheages of50and75 years couldreduce
thechanceofdevelopingordyingfromcolorectal
carcinoma by 10 to 75%, depending on which
screening tests are used and how often they are
done.' The increased reduction in mortality is
more likely to occur if the entire colon is
visualised, with less reliance on faecal occult
bloodtestsandflexiblesigmoidoscopy.Wewould
proposethatiftheentirecolonistobevisualised,
thenDCBEshouldbeconsideredasanappropriate
imaging method for screening.
Colonoscopy, although having the advantage of
biopsy and resection of lesions, also fails to
detect a small number of colonic carcinomas,
with a false negative rate reported as high as
10%.2 Furthermore, it is not always possible to
negotiate atortuous colon andreachthe caecum.
There is also a small risk of perforation during
colonoscopy. This has been estimated at 1 in
every 1000 diagnostic procedures, with a higher
rate ifpolypectomy is performed. The estimated
perforation rate during a DCBEis 1 in 25,000
examinations.3 Expense, a critical consideration
with a large screening programme, is another
factor favouring barium enema, with projected
costs showing DCBE to be less than halfthat of
colonoscopy. A disadvantage of DCBE is
radiation dose, which is estimated at 7mSv.4
We have demonstrated that the DCBE, as
performed at our institution, has a sensitivity of
96.5% and a false negative rate of 3.5% for the
detection of colorectal carcinoma in a
symptomatic population. Histopathology was
usedasthegoldstandard.Thisfalsenegativerate
compares well with previous studies reported in
theliterature.Johnsonetal5reportafalsenegative
rateof4.7%usingDCBEandBeggs etal 6afalse
negative rate of 8.6%. These were both
retrospective studies. A prospective study by
Forketal 7to assess theaccuracyofDCBEinthe
diagnosis of colorectal carcinoma identified a
99.3% accuracy in a patient cohort followed-up
forfouryears. Wedoacceptthatthenatureofour
study, as with similar retrospective studies, has
an element of selection bias, due to the fact that
somepatientswithnormalbariumenemasduring
the study period may nothave undergone further
evaluation and may have eventually been
diagnosed at another centre.
Our study looked at the detection of colorectal
carcinomainasymptomaticpopulation, however
there is an additional issue to be addressed when
considering screening in an asymptomatic
population. Although the detection of early
colorectal cancers is important, the detection of
adenomatous polyps is alsorequired, as itis now
acceptedthatthesearetheprecursorsofcolorectal
carcinomas. Studieshaveshownthatcolonoscopy
may be superior to DCBE in the detection of
polyps, with DCBE having an estimated
sensitivity of75-90% for adenomas greater than
1 cm in size, as opposed to colonoscopy with an
estimated sensitivity of approximately 90%.3
Polyps less than 1 cm in size have a low risk of
malignant potential (less than 1%) and therefore
ifproposedscreeningwithDCBEwasperformed
every 5 years, then there is areasonable window
for subsequent detection without detrimentally
affectingpatientoutcome. Forthepolyps greater
than1cminsizeatradeoffmustbemadebetween
the apparent greater sensitivity of colonoscopy
and the increased risks and costs associated with
this procedure.
The reasons for failing to identify adenomas or
early carcinomas on barium enema examination
are either due to perceptive errors by the
radiologist and/or due to technical inadequacies
of the examination. Both these factors were
present in our series with suboptimal bowel
preparation being a factor in two of the cases.
Othertechnicalconsiderationsincludeincomplete
air distension, insufficient tube angulation and
overexposed films.8 Concomitant diverticulosis
wasalsopresentintwoofthecasesincreasingthe
likelihood ofa perceptive error. These may also
occur due to missing the lesion in the barium
pool, or missing the lesion en face or in
overlapping loops.9 Radiographic findings in
overlooked colorectal carcinomas include subtle
changes in normal colon architecture.8 These
include concave or irregular mucosal barium
margins, convergenceofinter-haustralfolds,flat
or missing haustra, reduced caecal volume and
the presence oflocally fixed debris like lesions.
CONCLUSION
Both the colonoscopic and DCBE methods of
visualising the colon are in worldwide usage.
Both arewell-validatedtechniques, andeachhas
their proponents. Colonoscopy offers the
advantage of direct visualisation, biopsy and
excision oflesions. It has however, arecognised
technical failure rate, which may not be
insignificant, canbetechnicallychallenging, and
has a small risk of associated morbidity.
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The double contrast barium enema is a safe,
inexpensive alternative. Failure to visualise the
entire colon is rare, and the DCBE has the added
advantageofproducingastandardisedfilmseries,
which can be retrospectively scrutinised, as in
our series. This advantage has implications for
clinicalaudit, andqualityassuranceinascreening
program.
We conclude thattheDCBE, with its widespread
availability, relative inexpense and high
sensitivity, shouldmeritserious consideration as
an appropriate imaging method for colonic
evaluation in a future colorectal screening
program.
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